• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病中肠道纤维化发病机制的新见解:聚焦于肠道平滑肌细胞

New Insights into the Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Diseases: Focusing on Intestinal Smooth Muscle Cells.

作者信息

Kalafateli Maria, Tourkochristou Evanthia, Tsounis Efthymios P, Aggeletopoulou Ioanna, Triantos Christos

机构信息

Department of Gastroenterology, General Hospital of Patras, Patras, Greece.

Division of Hematology, Department of Internal Medicine, Medical School, University of Patras, Patras, Greece.

出版信息

Inflamm Bowel Dis. 2025 Feb 10;31(2):579-592. doi: 10.1093/ibd/izae292.

DOI:10.1093/ibd/izae292
PMID:39680685
Abstract

Strictures in inflammatory bowel disease, especially Crohn's disease (CD), are characterized by increased intestinal wall thickness, which, according to recent accumulating data, is mainly attributed to the expansion of the intestinal smooth muscle layers and to a lesser extent to collagen deposition. In this review, we will discuss the role of intestinal smooth muscle cells (SMCs) as crucial orchestrators of stricture formation. Activated SMCs can synthesize extracellular matrix (ECM), thus contributing to intestinal fibrosis, as well as growth factors and cytokines that can further enhance ECM production, stimulate other surrounding mesenchymal and immune cells, and increase SMC proliferation via paracrine or autocrine signaling. There is also evidence that, in stricturing CD, a phenotypic modulation of SMC toward a myofibroblast-like synthetic phenotype takes place. Moreover, the molecular mechanisms and signaling pathways that regulate SMC hyperplasia/hypertrophy will be extensively reviewed. The understanding of the cellular network and the molecular background behind stricture formation is essential for the design of effective anti-fibrotic strategies, and SMCs might be a promising therapeutic target in the future.

摘要

炎症性肠病,尤其是克罗恩病(CD)中的狭窄,其特征为肠壁厚度增加。根据最近积累的数据,这主要归因于肠道平滑肌层的扩张,其次是胶原沉积。在本综述中,我们将讨论肠道平滑肌细胞(SMC)作为狭窄形成的关键协调者的作用。活化的SMC可合成细胞外基质(ECM),从而导致肠道纤维化,还可合成生长因子和细胞因子,这些因子可进一步增强ECM的产生,刺激其他周围的间充质和免疫细胞,并通过旁分泌或自分泌信号增加SMC增殖。也有证据表明,在狭窄性CD中,SMC会向肌成纤维细胞样合成表型发生表型调节。此外,还将广泛综述调节SMC增生/肥大的分子机制和信号通路。了解狭窄形成背后的细胞网络和分子背景对于设计有效的抗纤维化策略至关重要,并且SMC未来可能是一个有前景的治疗靶点。

相似文献

1
New Insights into the Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Diseases: Focusing on Intestinal Smooth Muscle Cells.炎症性肠病中肠道纤维化发病机制的新见解:聚焦于肠道平滑肌细胞
Inflamm Bowel Dis. 2025 Feb 10;31(2):579-592. doi: 10.1093/ibd/izae292.
2
Smooth Muscle Hyperplasia/Hypertrophy is the Most Prominent Histological Change in Crohn's Fibrostenosing Bowel Strictures: A Semiquantitative Analysis by Using a Novel Histological Grading Scheme.平滑肌增生/肥大是克罗恩病纤维狭窄性肠狭窄最显著的组织学改变:使用新的组织学分级方案进行半定量分析。
J Crohns Colitis. 2017 Jan;11(1):92-104. doi: 10.1093/ecco-jcc/jjw126. Epub 2016 Jun 30.
3
Endogenous IGFBP-3 regulates excess collagen expression in intestinal smooth muscle cells of Crohn's disease strictures.内源性 IGFBP-3 调节克罗恩病狭窄处肠平滑肌细胞中胶原的过度表达。
Inflamm Bowel Dis. 2011 Jan;17(1):193-201. doi: 10.1002/ibd.21351.
4
Increased IGF-IEc expression and mechano-growth factor production in intestinal muscle of fibrostenotic Crohn's disease and smooth muscle hypertrophy.在纤维狭窄型克罗恩病的肠道肌肉中,胰岛素样生长因子-IEc表达增加以及机械生长因子产生,伴有平滑肌肥大。
Am J Physiol Gastrointest Liver Physiol. 2015 Dec 1;309(11):G888-99. doi: 10.1152/ajpgi.00414.2014. Epub 2015 Oct 1.
5
Can we prevent, reduce or reverse intestinal fibrosis in IBD?我们能否预防、减轻或逆转 IBD 中的肠道纤维化?
Eur Rev Med Pharmacol Sci. 2013 May;17(10):1283-304.
6
NR4A1 modulates intestinal smooth muscle cell phenotype and dampens inflammation-associated intestinal remodeling.NR4A1 调节肠道平滑肌细胞表型并抑制炎症相关的肠道重塑。
FASEB J. 2022 Nov;36(11):e22609. doi: 10.1096/fj.202101817RR.
7
Nr4A1 modulates inflammation-associated intestinal fibrosis and dampens fibrogenic signaling in myofibroblasts.Nr4A1 调节炎症相关的肠道纤维化,并抑制肌成纤维细胞中的纤维生成信号。
Am J Physiol Gastrointest Liver Physiol. 2021 Sep 1;321(3):G280-G297. doi: 10.1152/ajpgi.00338.2019. Epub 2021 Jul 21.
8
Intestinal fibrosis associated with inflammatory bowel disease: Known and unknown.与炎症性肠病相关的肠道纤维化:已知与未知
Chin Med J (Engl). 2025 Apr 20;138(8):883-893. doi: 10.1097/CM9.0000000000003545. Epub 2025 Feb 27.
9
Role of non-inflammatory factors in intestinal fibrosis.非炎症因素在肠道纤维化中的作用。
J Dig Dis. 2020 Jun;21(6):315-318. doi: 10.1111/1751-2980.12883.
10
Cellular and Molecular Mediators of Intestinal Fibrosis.肠道纤维化的细胞和分子介质。
J Crohns Colitis. 2017 Dec 4;11(12):1491-1503. doi: 10.1016/j.crohns.2014.09.008.

引用本文的文献

1
Intestinal Fibrosis in Crohn's Disease: Pathophysiology, Diagnosis, and New Therapeutic Targets.克罗恩病中的肠道纤维化:病理生理学、诊断及新治疗靶点
J Clin Med. 2025 Jun 8;14(12):4060. doi: 10.3390/jcm14124060.
2
Exploring shared pathogenic mechanisms and biomarkers in hepatic fibrosis and inflammatory bowel disease through bioinformatics and machine learning.通过生物信息学和机器学习探索肝纤维化和炎症性肠病的共同致病机制及生物标志物。
Front Immunol. 2025 May 12;16:1533246. doi: 10.3389/fimmu.2025.1533246. eCollection 2025.
3
Therapeutic potential of Janus kinase inhibitors for the management of fibrosis in inflammatory bowel disease.
Janus激酶抑制剂在炎症性肠病纤维化管理中的治疗潜力。
J Crohns Colitis. 2025 Jun 4;19(6). doi: 10.1093/ecco-jcc/jjaf087.